• Profile
Close

Identification of prognostic and therapeutic value of CC chemokines in urothelial bladder cancer: Evidence from comprehensive bioinformatic analysis

BMC Urology Dec 16, 2021

Li Y, Chen X, Li D, et al. - Analyzing the function of distinct CC chemokines in urothelial bladder cancer (BC), a significantly better prognosis of BC patients was observed in relation to high expression levels of CCL1, CCL2, CCL3, CCL4, CCL5, CCL8, CCL13, CCL15, CCL17, CCL18, CCL19, CCL22, CCL25, CCL27.

  • In this study, ONCOMINE, Gene Expression Profiling Interactive Analysis, Kaplan–Meier plotter, cBioPortal, GeneMANIA, and TIMER were utilized.

  • In BC patients, a significant decrease in transcriptional levels of CCL2/3/4/5/14/19/21/23 was evident.

  • Expression of CCL2/11/14/18/19/21/23/24/26 was significantly related to the pathological stage of BC patients.

  • Differentially expressed CC chemokines were shown to be primarily correlated with cytokine activity, chemokines receptor binding, chemotaxis, immune cell migration.

  • In addition, the expression of CC chemokines were significantly correlated with infiltration of various types of immune cells (B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay